BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23546714)

  • 1. Fibrinogen.
    Stang LJ; Mitchell LG
    Methods Mol Biol; 2013; 992():181-92. PubMed ID: 23546714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Fibrinogen and Thrombin Time (TT).
    Undas A
    Methods Mol Biol; 2017; 1646():105-110. PubMed ID: 28804822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
    Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
    Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin clotting time.
    Ignjatovic V
    Methods Mol Biol; 2013; 992():131-8. PubMed ID: 23546710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative reagent-free detection of fibrinogen levels in human blood plasma using Raman spectroscopy.
    Poon KW; Lyng FM; Knief P; Howe O; Meade AD; Curtin JF; Byrne HJ; Vaughan J
    Analyst; 2012 Apr; 137(8):1807-14. PubMed ID: 22382127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reptilase time (RT).
    Karapetian H
    Methods Mol Biol; 2013; 992():273-7. PubMed ID: 23546720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an automated photometric fibrinogen assay.
    Oosting JD; Hoffmann JJ
    Blood Coagul Fibrinolysis; 1997 Sep; 8(6):321-6. PubMed ID: 9351521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma.
    Zhao X; Wang Z; Cao L; Zhang W; Bai X; Dong N; Yu Z; Ruan C
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):398-405. PubMed ID: 20410814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of argatroban on five fibrinogen assays.
    Zhang L; Yang J; Zheng X; Fan Q; Zhang Z
    Int J Lab Hematol; 2017 Dec; 39(6):641-644. PubMed ID: 28766891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
    Arai S; Kamijo T; Hayashi F; Shinohara S; Arai N; Sugano M; Uehara T; Honda T; Okumura N
    Int J Lab Hematol; 2021 Apr; 43(2):281-289. PubMed ID: 33030793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prothrombin time-derived and Clauss assays for the measurement of plasma fibrinogen in hospitalized dogs.
    Hasiuk MH; Russell KE; Jeffery U
    Vet Clin Pathol; 2020 Sep; 49(3):394-400. PubMed ID: 32654209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of fibrinogen in plasma.
    Morse EE; Viswanathan U
    Ann Clin Lab Sci; 1978; 8(5):438-41. PubMed ID: 707979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.
    Kalina U; Stöhr HA; Bickhard H; Knaub S; Siboni SM; Mannucci PM; Peyvandi F
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):777-83. PubMed ID: 19002044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
    Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
    Anesth Analg; 2012 Jul; 115(1):16-21. PubMed ID: 22467887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.